Matches in Wikidata for { <http://www.wikidata.org/entity/Q68160539> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q68160539 description "articolo scientifico (pubblicato il 1986)" @default.
- Q68160539 description "artigo científico (publicado na 1986)" @default.
- Q68160539 description "artikull shkencor i botuar më 01 janar 1986" @default.
- Q68160539 description "artículu científicu espublizáu en 1986" @default.
- Q68160539 description "im Jahr 1986 veröffentlichter wissenschaftlicher Artikel" @default.
- Q68160539 description "scientific article published on 01 January 1986" @default.
- Q68160539 description "wetenschappelijk artikel" @default.
- Q68160539 description "наукова стаття, опублікована в січні 1986" @default.
- Q68160539 name "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 name "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 name "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 type Item @default.
- Q68160539 label "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 label "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 label "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 prefLabel "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 prefLabel "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 prefLabel "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 P1433 Q68160539-8D554433-D72B-41CB-9714-DF8F7C3AE3B7 @default.
- Q68160539 P1476 Q68160539-E6017D55-274E-4BCB-82E7-F242414157B8 @default.
- Q68160539 P2093 Q68160539-262C5B5D-9FA3-4CF8-9ACB-D0867CFC2037 @default.
- Q68160539 P2093 Q68160539-90E00F63-A09D-4152-82C5-12F24CDB1F6C @default.
- Q68160539 P2093 Q68160539-90EF247F-9BB7-41EE-86B7-BF8EACC92AF1 @default.
- Q68160539 P2093 Q68160539-FB74E356-45CF-4566-91F6-5F5925276F83 @default.
- Q68160539 P304 Q68160539-B70108FD-D0CE-426A-B826-5786AB6FFFB4 @default.
- Q68160539 P31 Q68160539-C71F7E5A-D2A0-44AD-9741-2500344DA747 @default.
- Q68160539 P478 Q68160539-02E43921-67A5-47F2-A1D4-0A153BB88B00 @default.
- Q68160539 P577 Q68160539-E543DFF8-DC82-4339-8260-88A38EA9F417 @default.
- Q68160539 P698 Q68160539-02567EE8-1477-4254-8223-9FB5ED5541AB @default.
- Q68160539 P698 3297320 @default.
- Q68160539 P1433 Q15753218 @default.
- Q68160539 P1476 "Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning" @default.
- Q68160539 P2093 "Benedetti N" @default.
- Q68160539 P2093 "Caltagirone C" @default.
- Q68160539 P2093 "Gainotti G" @default.
- Q68160539 P2093 "Nocentini U" @default.
- Q68160539 P304 "S65-9" @default.
- Q68160539 P31 Q13442814 @default.
- Q68160539 P478 "9 Suppl 3" @default.
- Q68160539 P577 "1986-01-01T00:00:00Z" @default.
- Q68160539 P698 "3297320" @default.